A1336 - 2′-FL from GM Escherichia coli BL21 in infant formula products

Published

This application seeks to permit a new genetically modified source of Escherichia coli BL21 (DE3) for the production of 2′-fucosyllactose (2′-FL) for use as a nutritive substance in infant formula products.

Administrative Assessment